Anti-GGT6 monoclonal antibody

Pre-made anti-GGT6 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GGT6/GGT6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0902-Ab-1/ GM-Tg-hg-IP0902-Ab-2Anti-Human GGT6 monoclonal antibodyHuman
GM-Tg-rg-IP0902-Ab-1/ GM-Tg-rg-IP0902-Ab-2Anti-Rat GGT6 monoclonal antibodyRat
GM-Tg-mg-IP0902-Ab-1/ GM-Tg-mg-IP0902-Ab-2Anti-Mouse GGT6 monoclonal antibodyMouse
GM-Tg-cynog-IP0902-Ab-1/ GM-Tg-cynog-IP0902-Ab-2Anti-Cynomolgus/ Rhesus macaque GGT6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0902-Ab-1/ GM-Tg-felg-IP0902-Ab-2Anti-Feline GGT6 monoclonal antibodyFeline
GM-Tg-cang-IP0902-Ab-1/ GM-Tg-cang-IP0902-Ab-2Anti-Canine GGT6 monoclonal antibodyCanine
GM-Tg-bovg-IP0902-Ab-1/ GM-Tg-bovg-IP0902-Ab-2Anti-Bovine GGT6 monoclonal antibodyBovine
GM-Tg-equg-IP0902-Ab-1/ GM-Tg-equg-IP0902-Ab-2Anti-Equine GGT6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0902-Ab-1/ GM-Tg-hg-IP0902-Ab-2; GM-Tg-rg-IP0902-Ab-1/ GM-Tg-rg-IP0902-Ab-2;
GM-Tg-mg-IP0902-Ab-1/ GM-Tg-mg-IP0902-Ab-2; GM-Tg-cynog-IP0902-Ab-1/ GM-Tg-cynog-IP0902-Ab-2;
GM-Tg-felg-IP0902-Ab-1/ GM-Tg-felg-IP0902-Ab-2; GM-Tg-cang-IP0902-Ab-1/ GM-Tg-cang-IP0902-Ab-2;
GM-Tg-bovg-IP0902-Ab-1/ GM-Tg-bovg-IP0902-Ab-2; GM-Tg-equg-IP0902-Ab-1/ GM-Tg-equg-IP0902-Ab-2
Products NameAnti-GGT6 monoclonal antibody
Formatmab
Target NameGGT6
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GGT6 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0902-Ag-1Recombinant multi-species GGT6 protein


    Target information

    Target IDGM-IP0902
    Target NameGGT6
    Gene ID124975,71522,408206,100427144,606867,101087792,613919,100060762
    Gene Symbol and Synonyms9030405D14Rik,GGT6
    Uniprot AccessionQ6P531,Q6IE08,A7YWM1
    Uniprot Entry NameGGT6_HUMAN,GGT6_RAT,GGT6_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000167741
    Target ClassificationN/A

    The target: GGT6, gene name: GGT6, also named as . GGT6 belongs to the gamma-glutamyltransferase (GGT; EC 2.3.2.2) gene family. GGT is a membrane-bound extracellular enzyme that cleaves gamma-glutamyl peptide bonds in glutathione and other peptides and transfers the gamma-glutamyl moiety to acceptors. GGT is also key to glutathione homeostasis because it provides substrates for glutathione synthesis (Heisterkamp et al., 2008 [PubMed 18357469]).[supplied by OMIM, Oct 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.